Home > Insider Trading > Filing (0001225208-25-001878)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1629277	Bradley John Sorenson	300 Boston Scientific Way Marlborough MA 01752-1234	Evp, Global Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-02-14	2,115	$0.00	27,609	No	4	M	Direct
Common Stock	Disposition	2025-02-14	965	$106.11	26,644	No	4	F	Direct
Common Stock	Disposition	2025-02-14	1,201	$106.31	25,443	No	4	S	Direct
Common Stock	Acquisiton	2025-02-16	1,273	$0.00	26,716	No	4	M	Direct
Common Stock	Disposition	2025-02-16	581	$106.11	26,135	No	4	F	Direct
Common Stock	Acquisiton	2025-02-17	1,500	$0.00	27,635	No	4	M	Direct
Common Stock	Disposition	2025-02-17	684	$106.11	26,951	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2025-02-13	4,239	$0.00	4,239	$0.00
Common Stock	Stock Option (Right to Buy)	Acquisiton	2025-02-13	10,909	$0.00	10,909	$106.14
Common Stock	Restricted Stock Units	Disposition	2025-02-14	2,115	$0.00	2,115	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-02-16	1,273	$0.00	1,273	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-02-17	1,500	$0.00	1,500	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,239	2029-02-13	No	4	A	Direct
10,909	2035-02-13	No	4	A	Direct
4,230	2027-02-14	No	4	M	Direct
1,273	2026-02-16	No	4	M	Direct
0	2025-02-17	No	4	M	Direct

Footnotes

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.